BioSpace News Archive

Business

AGC Biologics Announces Change in Executive Leadership

Mark Womack to Succeed Robert Broeze, PhD as Chief Business Officer of AGC Biologics

January 7, 2019
·
2 min read
Pharm Country

WindRose Health Investors Closes Fund V at $705 Million

WindRose Health Investors, LLC has closed its fifth fund, WindRose Health Investors V, L.P. (“Fund V”) with $705 million in limited partner and general partner commitments. The fund was over-subscribed and closed at its fundraising cap.

January 7, 2019
·
1 min read
Policy

Neptune Receives License to Process Cannabis from Health Canada

Neptune Wellness Solutions Inc. is pleased to announce today that it has received its license to process cannabis from Health Canada.

January 7, 2019
·
6 min read
Drug Development

Syndax Highlights 2019 Clinical and Corporate Outlook

Data from ENCORE I/O combination program in melanoma and ovarian cancer expected in 1Q19, TNBC in 2Q19

January 7, 2019
·
7 min read
Pharm Country

Regeneron Provides Update on Commercial and Pipeline Progress at J.P. Morgan Healthcare Conference

Regeneron Pharmaceuticals, Inc. will provide a strategic business update to the investor community at the 37th Annual J.P. Morgan Healthcare Conference

January 7, 2019
·
14 min read
Job Trends

VRHealth Announces First Telehealth-VR Medical Platform For Consumers

Platform Informed by Learnings from Collaboration with AARP

January 7, 2019
·
3 min read
Business

Actress Vanessa Hudgens Named American Cancer Society Global Ambassador; Joins Super Bowl Sweepstakes

The American Cancer Society (ACS) welcomes a new global ambassador, actress Vanessa Hudgens, who is participating in an exclusive Super Bowl LIII weekend package to raise critical funds to fight cancer.

January 7, 2019
·
5 min read
Business

Protagonist Therapeutics Appoints Suneel K. Gupta, Ph.D., as Executive Vice President of Clinical Operations and Pharmacology

Protagonist Therapeutics, Inc. announced the appointment of Suneel Gupta, Ph.D., as Executive Vice President of Clinical Operations and Clinical Pharmacology

January 7, 2019
·
4 min read
Genetown

Frequency Therapeutics Completes $42 Million Series B Financing

Joel Marcus, Executive Chairman and Founder of Alexandria Real Estate Equities, Inc. and Alexandria Venture Investments, and Michael Huang, Managing Partner at Taiwania Capital Management, join Board of Directors

January 7, 2019
·
3 min read
Pharm Country

Catalent Invests $200 Million to Expand Biologics Capacity and Capabilities

Catalent, Inc. today announced it has commenced a $200 million capital investment in its Biologics business to expand drug substance manufacturing capacity and drug product fill/finish capacity due to projected growth among existing and future customers.

January 7, 2019
·
3 min read